Cardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 124, Issue 11, Pages 4795-4806
Publisher
American Society for Clinical Investigation
Online
2014-10-20
DOI
10.1172/jci76737
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Cell-Based Phenotypic Assay to Identify Cardioprotective Agents
- (2012) Stephanie Guo et al. CIRCULATION RESEARCH
- Examining the safety of PPAR agonists – current trends and future prospects
- (2012) Michele Bortolini et al. Expert Opinion On Drug Safety
- Dietary obesity-associated Hif1 activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system
- (2012) J. Krishnan et al. GENES & DEVELOPMENT
- Diabetic cardiomyopathy and metabolic remodeling of the heart
- (2012) Pavan K. Battiprolu et al. LIFE SCIENCES
- Disruption of ATP-binding cassette B8 in mice leads to cardiomyopathy through a decrease in mitochondrial iron export
- (2012) Y. Ichikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
- (2011) J. Schodel et al. BLOOD
- Lipotoxicity in type 2 diabetic cardiomyopathy
- (2011) Tineke van de Weijer et al. CARDIOVASCULAR RESEARCH
- Mice with a Targeted Deletion of the Type 2 Deiodinase Are Insulin Resistant and Susceptible to Diet Induced Obesity
- (2011) Alessandro Marsili et al. PLoS One
- High fat diet induced diabetic cardiomyopathy
- (2011) Ellen Dirkx et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Reduction in Hexokinase II Levels Results in Decreased Cardiac Function and Altered Remodeling After Ischemia/Reperfusion Injury
- (2010) Rongxue Wu et al. CIRCULATION RESEARCH
- PPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation
- (2010) Ni-Huiping Son et al. JOURNAL OF CLINICAL INVESTIGATION
- Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease
- (2009) Jean-Charles Fruchart ATHEROSCLEROSIS
- Ablation of ARNT/HIF1β in Liver Alters Gluconeogenesis, Lipogenic Gene Expression, and Serum Ketones
- (2009) Xiaohui L. Wang et al. Cell Metabolism
- Activation of a HIF1α-PPARγ Axis Underlies the Integration of Glycolytic and Lipid Anabolic Pathways in Pathologic Cardiac Hypertrophy
- (2009) Jaya Krishnan et al. Cell Metabolism
- Avoidance of Transient Cardiomyopathy in Cardiomyocyte-Targeted Tamoxifen-Induced MerCreMer Gene Deletion Models
- (2009) Norimichi Koitabashi et al. CIRCULATION RESEARCH
- GATA-2 Reinforces Megakaryocyte Development in the Absence of GATA-1
- (2009) Z. Huang et al. MOLECULAR AND CELLULAR BIOLOGY
- Regulation of endocytosis via the oxygen-sensing pathway
- (2009) Yi Wang et al. NATURE MEDICINE
- Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease
- (2009) Emma Robinson et al. PHARMACOLOGY & THERAPEUTICS
- Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome
- (2008) Heiko Bugger et al. CLINICAL SCIENCE
- Three good reasons for heart surgeons to understand cardiac metabolism☆
- (2008) Torsten Doenst et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- The PPAR trio: Regulators of myocardial energy metabolism in health and disease
- (2008) Jose A. Madrazo et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started